CA - Bausch Health drops after suing Amneal Pharma over Xifaxan generic
2024-04-08 15:32:37 ET
More on Bausch Health Companies
- Bausch Health: A Timely Divestiture Is The Key To An Higher Valuation
- Bausch Health Companies (BHC) Q4 2023 Earnings Call Transcript
- Bausch Health sues Amneal Pharma over Xifaxan generic
- Bausch Health Companies beats top-line and bottom-line estimates; initiates FY24 outlook
- Seeking Alpha’s Quant Rating on Bausch Health Companies